PUBLICATION

In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice

Authors
Nieoczym, D., Banono, N.S., Stępnik, K., Kaczor, A.A., Szybkowski, P., Esguerra, C.V., Kukula-Koch, W., Gawel, K.
ID
ZDB-PUB-230827-57
Date
2023
Source
International Journal of Molecular Sciences   24(16): (Journal)
Registered Authors
Banono, Nancy, Esguerra, Camila V., Gawel, Kinga Aurelia
Keywords
local field potential recordings, mice, molecular modeling, pentylenetetrazole, schisandrin B, seizures, toxicity, zebrafish
MeSH Terms
  • Animals
  • Anticonvulsants*/toxicity
  • Glutamic Acid
  • Larva
  • Mice
  • Molecular Docking Simulation
  • Pentylenetetrazole/toxicity
  • Receptors, GABA-A
  • Seizures/chemically induced
  • Seizures/drug therapy
  • Zebrafish*
PubMed
37629132 Full text @ Int. J. Mol. Sci.
Abstract
The aim of this study is to evaluate the anticonvulsant potential of schisandrin B, a main ingredient of Schisandra chinensis extracts. Schisandrin B showed anticonvulsant activity in the zebrafish larva pentylenetetrazole acute seizure assay but did not alter seizure thresholds in the intravenous pentylenetetrazole test in mice. Schisandrin B crosses the blood-brain barrier, which we confirmed in our in silico and in vivo analyses; however, the low level of its unbound fraction in the mouse brain tissue may explain the observed lack of anticonvulsant activity. Molecular docking revealed that the anticonvulsant activity of the compound in larval zebrafish might have been due to its binding to a benzodiazepine site within the GABAA receptor and/or the inhibition of the glutamate NMDA receptor. Although schisandrin B showed a beneficial anticonvulsant effect, toxicological studies revealed that it caused serious developmental impairment in zebrafish larvae, underscoring its teratogenic properties. Further detailed studies are needed to precisely identify the properties, pharmacological effects, and safety of schisandrin B.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping